# Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction

> **NCT06344312** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Stroke, Acute Ischemic

## Interventions

- **DRUG:** Yangxue Qingnao Granules

## Key facts

- **NCT ID:** NCT06344312
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344312, "Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction". Retrieved via MORVS 2026-10-09 from https://api.morvs.ai/clinical/NCT06344312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*